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Abstract
Background: Acantholytic squamous cell carcinoma (ASCC) is an uncommon histopathologic variant of SCC,
characterized by marked acantholysis, wherein the tumor cells demonstrate defective cohesion to one another in
the cancer nest leading to a pseudoglandular or pseudovascular appearance. The most common site of ASCC is
the sun-exposed areas of the skin. Sporadic cases of ASCC have also been reported in various mucosal membranes
and organs but to our knowledge this is the first case of primary ASCC of the large bowel.
Case presentation: A 59-year-old woman underwent right hemicolectomy due to large tumor in cecum and
initial part of the ascending colon. Microscopically, the tumor consisted of nests of focally keratinizing large,
atypical, squamous epithelial cells. Approximately 70% of the tumor showed acantholytic changes and acantholysis
was equally distributed through the entire tumor. Immunohistochemically tumor cells were diffusely positive for
cytokeratin (CK) AE1/AE3 and focally positive for epithelial membrane antigen and syndecan 1. All other tested
antibodies (CK7, CK 20, CK MNF116, E-cadherin, beta-catenin, p63, p16, CD31, CD34, CEA, estrogen, progesterone)
showed negative reaction. Periodic acid Schiff and alcian blue staining showed no intracellular or extracellular
mucinous material in the tumor. The diagnosis of acantholytic squamous cell carcinoma of the cecum was
suspected and additional examination was recommended to exclude possibility of metastatic carcinoma. Extensive
clinical examination which also included whole-body PET/CT scan showed no additional tumors. After the
exclusion of possible metastatic disease the diagnosis of primary acantholytic squamous cell carcinoma of the
cecum was confirmed. Six months after surgery the metastasis in small intestine and recurrence in the abdominal
cavity at the site of surgery appeared and had the same morphological characteristic as the primary tumor in the
cecum.
Conclusion: We report a unique case of ASCC arising in cecum and on this way expands the range of tumors
originating in colon. Reports of more cases of colonic ASCC would possibly help to elucidate origin, clinical
behavior and therapy of these tumors.
Background
Primary squamous cell carcinoma (SCC) of the cecum is
rare entity and only limited numbers of cases are
d e s c r i b e d[ 1 - 4 ] .T h ef i r s tc a s eo fS C Cw a sr e p o r t e db y
Schmidtman in 1919 [5]. Acantholytic squamous cell
carcinoma (ASCC) is an uncommon histopathologic var-
iant of SCC, characterized by marked acantholysis,
wherein the tumor cells demonstrate defective cohesion
to one another in the cancer nest leading to a pseudo-
glandular or pseudovascular appearance [6]. It was first
described in details by Lever [7] in 1947 as adenoa-
canthoma of the sweat glands. Synonyms include ade-
noid SCC, pseudoglandular SCC, SCC with gland-like
features, angiosarcoma-like SCC, and pseudovascular
adenoid SCC. The most common site of ASCC is the
sun-exposed areas of the skin, particularly on the head
and neck of elderly men [6]. Sporadic cases of ASCC
have also been reported in various mucosal membranes
and organs [8-12] but to our knowledge this is the first
case of primary ASCC of the large bowel.
Case presentation
A 59-year-old woman who presented with a one month
history of lower abdominal pain and intermittent watery,
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examination, she was found to have right lower quad-
rant abdominal tenderness without guarding. Blood tests
revealed anemia and C reactive protein was slightly ele-
vated. Her past medical history included hysterectomy
due to multiple myomas 25 years earlier and segmen-
tectomy of right breast 3 years ago. Patohistological
diagnosis of breast lesion was fibrocystic breast disease
with usual and atypical intraductal epithelial prolifera-
tion and foci of adenosis without sign of intraductal or
invasive carcinoma. Her mother and brother died from
conventional colon cancer in age of 69 and 63 years,
respectively. Father died of small cell lung cancer in the
age of 67 years. Colonoscopy was performed and
showed large tumor in cecum and initial part of the
ascending colon. A biopsy confirmed malignant nature
of the process and diagnosis of squamous cell carcinoma
was suggested. Abdominal CT showed large tumor in
cecoascending region of the colon and enlarged regional
lymph nodes. Signs of distant metastasis are not found.
Chest X-ray was unremarkable. A right hemicolectomy
with removal of adjacent pericolic lymph nodes was car-
ried out.
Grossly, in the cecoascending region, an ulcero-prolif-
erative, whitish-gray tumor measuring 9 cm in maxi-
m u md i a m e t e rw a sf o u n d( F i g u r e1 Aa n d1 B ) .
Microscopically, the tumor consisted of nests of focally
keratinizing, atypical, squamous epithelial cells (Figure
1C). Approximately 70% of the tumor showed acantho-
lytic changes and acantholysis was equally distributed
through the entire tumor (Figure 1D). In the lumen-like
pseudoglandular spaces, detached keratinocytes and
inflammatory cell were detected (Figure 1E). Tumor
cells were large with bright eosinophilic, focally glassy
cytoplasm and vesicular nuclei with small to medium
sized nucleoli (Figure 1F). The spindle cell carcinoma
elements were not found. The tumor infiltrated all
layers of the bowel wall and spread deeply into the sur-
rounding fatty tissue. Twenty-two lymph nodes received
with the specimen did not show any metastases.
Immunohistochemical staining was performed follow-
ing the microwave streptavidin immunoperoxidase
(MSIP) protocol on DAKO TechMate Horizon auto-
mated immunostainer using the following primary anti-
bodies: cytokeratin (CK) AE1/AE3, CK7, CK 20, CK
MNF116, EMA, E-cadherin, beta-catenin, p63, p16,
CD31, CD34, CEA, estrogen, progesterone (all antibo-
dies were purchased from DAKO, Denmark). Appropri-
ate positive and negative control was used for each
antibody. Periodic acid Schiff and alcian blue staining
were made following the standard procedure.
Immunohistochemically tumor cells were diffusely
positive for CK AE1/AE3 (Figure 1G) and focally posi-
tive for epithelial membrane antigen and syndecan 1
(Figure 1H). All other tested antibodies showed negative
reaction. Periodic acid Schiff and alcian blue staining
showed no intracellular or extracellular mucinous
material in the tumor, including acantholytic and pseu-
doglandular areas. The microscopic features of the
tumor-cecum mucosa boundary indicated primary
tumor (Figure 2A and 2B) and the diagnosis of acantho-
lytic squamous cell carcinoma of the cecum were sus-
pected. Additional extensive examination was
recommended to exclude possibility of metastatic carci-
noma. The patient underwent gynecological, head and
neck and pulmological examination. Clinical examina-
tion and pelvic and breast ultrasound, mammography,
head and neck and lung MRI found no additional
tumor. Finally, the patient underwent whole-body PET/
CT scan which also showed no additional tumors. After
the exclusion of possible metastatic disease the diagnosis
of primary acantholytic squamous cell carcinoma of the
cecum was confirmed.
The patient had no complications during the post-
operative course and was discharged 12 days after sur-
gery with suggested oncological examination and
treatment. Additional chemotherapy was performed and
the patients received 5-florouracil and folinic acid dur-
ing six months. Radiation therapy was not applied. Six
months after surgery the metastasis in small intestine
and recurrence in the abdominal cavity at the site of
surgery appeared and had the same morphological char-
acteristic as the primary tumor in the cecum.
Discussion
In ASCC of the skin and breast different molecular
alterations have been associated with loss of cellular
adhesion, including loss of E-cadherin or syndecan-1
[12,13]. In our case tumor cell showed loss of E-cadherin
and beta-catenin while syndecan-1 expression was
reduced and confined on small group of detached malig-
nant cell. Loss of E-cadherin, beta-catenin and altered
syndecan-1 expression suggest an impaired cellular adhe-
sion, which may explain the peculiar histological appear-
ance of these tumors and contribute to the observed
aggressive clinical behavior in skin, penile and breast
ASCC [6,10,12]. In our case tumor had also aggressive
course but making conclusions about clinical behavior of
this type tumor in colon are difficult because this is a
first case described with limited follow-up.
Before regarding such a case as primary SCC of the
colon, especially when tumor is located 7 cm proximal
to the dentate line, exclusion of possibilities of meta-
static deposit from a source elsewhere or direct exten-
sion from other site is necessary [1,14]. In addition, the
affected segment of bowel could not be in continuity
with squamous lined fistula or the anal squamous
epithelium, mucin should be absent, intercellular bridges
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Page 2 of 5Figure 1 Macroscopic, microscopic and immunohistochemical features of the acantholytic squamous cell carcinoma of the cecum. (A)
Grossly, in the cecoascending region, an ulcero-proliferative, whitish-gray tumor was found. (B) The tumor infiltrated all layers of the bowel wall
and spread deeply into the surrounding fatty tissue. (C) Microscopically, the tumor consisted of large, atypical, squamous epithelial cells with
abundant keratin formation (H&E, × 100). (D) Large areas of tumor showed prominent acantholythic changes (H&E, × 100). (E) Pseudoglandular
formation with detached keratinocytes and inflammatory cells were also detected (H&E, × 100). (F) Tumor cells were large with bright
eosinophilic, focally glassy cytoplasm and vesicular nuclei with small to medium sized nucleoli (400×). (G) Immunohistochemically tumor cells
were diffusely positive for cytokeratin AE1/AE3 including acantholytic and pseudoglandular area (× 200). (H) Syndecan-1 expression was reduced
and confined on small group of detached malignant cell (× 200).
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[1,14]. Some predisposing conditions are thought to play
a role in the development of primary colonic SCC such
as inflammatory bowel disease (especially ulcerative coli-
tis), schistostomiasis, pelvic irradiation, villous adenoma
and duplication of the intestine [1-4,14]. Our patient
had no any mentioned predisposing conditions but her
family history could suggest some genetic alterations
that may have role in tumor formation and especially
suspected was Lynch syndrome. Lynch syndrome or
hereditary non-polyposis colorectal cancer (HNPCC) is
an autosomal dominant genetic condition which is char-
acterized with a high risk of colon cancer as well as
other cancers including endometrium, ovary, stomach,
small intestine, hepatobiliary tract, upper urinary tract,
brain, and skin. The increased risk for these cancers is
due to inherited mutations that impair DNA mismatch
repair. Patients with Lynch syndrome usually present
with adenocarcinoma of the proximal colon (cecum),
with or without synchronous or metachronous colorec-
tal cancer or other malignancy typical of the syndrome.
The majority of colorectal carcinomas arising in Lynch
syndrome are generally similar to sporadic colorectal
cancer but mucinous, signet-ring and medullary types
are identified with increased frequency in Lynch syn-
drome patients [15]. In addition, the presence of tumor-
infiltrating lymphocytes and especially presence of
intraepithelial T-lymphocytes could identify the majority
of colorectal cancers with this mutation [16]. Despite
patient denied additional cancers in family and did not
know type and localization of colorectal cancer in rela-
tives we recommended additional genetic testing to
exclude possibility of Lynch syndrome.
We also considered HPV as potential carcinogen but
immunostaining for p16 was negative and therefore
additional investigations were not performed.
It is important for pathologist to discriminate between
primary colonic ASCC and metastasis of any SCC or
ASCC from elsewhere. Likewise, metastasis of endome-
troid carcinoma with squamous differentiation or
transitional cell carcinoma with gland formation and
squamous differentiation should be taken into consid-
eration. Endometroid carcinomas are immunohisto-
chemically positive for CK7, progesterone and estrogen
receptors while transitional cell carcinomas are positive
for CK7 and CK20. In our case these markers were
negative and CK AE1/AE3 was strongly and diffusely
positive in whole tumor including pseudoglandular and
acantholytic areas. Recommended additional extensive
clinical examination and immunohistochemical analysis
excluded possible metastatic disease and patient fulfils
all criteria for diagnosis of primary ASCC carcinoma.
There are four main proposed pathogenic theories try-
ing to explain the origin of SCC of the colon [1,2].
Squamous cells which are the source for SCC could ori-
ginate from proliferation of uncommitted reserve or
basal cells following mucosal injury, from squamous
metaplasia of glandular epithelium resulting from
chronic irritation, from embryonal nests of ectodermal
cells or from stem cells [1,2].
Colonic ASCC should be also differentiated from
adenosquamous carcinoma and angiosarcoma. Adenos-
quamous carcinoma is defined as a tumor with malig-
nant glandular and squamous component and the
potential for metastases [17]. In the colon and rectum,
this tumor is extremely rare and accounts for 0.1% to
0.2% of all colon cancers. Histogenesis of adenosqua-
mous carcinoma is unclear and several theories, that
are similar to theories of origin of colonic SCC, have
been proposed to try to explain squamous differentia-
tion in colonic mucosa [17]. Malignant glandular com-
ponent in adenosquamous colonic carcinoma retain
immunohistochemical characteristic of conventional
colonic adenocarcinoma (positivity for CK20 and CEA)
and contain mucinous material in the lumen or cells
cytoplasms [17].
Another rare tumor to be distinguished from ASCC is
the angiosarcoma, especially in the variant of ASCC
termed pseudovascular or angiosarcoma-like SCC where
anastomosing spaces and channels that are mimicking
neoplastic vessels of angiosarcoma are formed and kera-
tin formation is absent [8,9]. Angiosarcoma occurs very
rarely in the intestinal tract as either primary or meta-
static malignancy and can present great diagnostic diffi-
culty, especially when it displays epithelioid
cytomorphology [18]. An incorrect diagnosis of angio-
sarcoma may lead to inappropriate treatment and prog-
nosis. Immunohistochemical examination is a useful
tool in making the distinction but cytokeratins and
epithelial membrane antigen should not be considered
to be a distinct discriminating criterion, because malig-
nant endothelial cells may be positive [18]. Allison et al.
[18] immunohistochemically analyzed a series of 8 pri-
mary and metastatic angiosarcoma involving the
Figure 2 The tumor-cecum mucosa boundary of the
acantholytic squamous cell carcinoma of the cecum. (A) The
tumor began in the colonic mucosa and was top heavy (H&E, × 40).
(B) The tumor-cecum mucosa boundary also indicated primary
tumor (H&E, × 200).
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immunoreactive for cytokeratins AE1/AE3 (7/8), cyto-
keratin 7 (2/8), Cam5.2/cytokeratin 8 (5/8), and cytoker-
atin 19 (5/8). In one case weakly and focal positivity for
epithelial membrane antigen was also observed [18]. In
contrast to an angiosarcoma, the cells of ASCC are
negative for endothelial markers such as CD31, CD34
and von Willebrand factor and these markers must be
included in differentiating ASCC from angiosarcoma
[8,9,18].
The immunohistochemical and histochemical findings
of the present tumor were compatible with the previous
data of ASCC and exclude possibility of adenosquamous
carcinoma or angiosarcoma [8-13].
Conclusion
We report a unique case of ASCC arising in cecum and
on this way expands the range of tumors originating in
colon. Reports of more cases of colonic ASCC would
possibly help to elucidate origin, clinical behavior and
therapy of these tumors.
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